HomeAnswersMedical oncologyrenal cancerMy father has papillary renal cell carcinoma. Which drug has a similar effect of Sustent?

Other than Sutent, which medicine can I opt for papillary renal cell carcinoma?

Share

The following is an actual conversation between an iCliniq user and a doctor that has been reviewed and published as a Premium Q&A.

Medically reviewed by

Dr. Nithila. A

Published At June 24, 2019
Reviewed AtJune 24, 2019

Patient's Query

Hello doctor,

My father is recently diagnosed with papillary renal cell carcinoma type 1, and he has no BP or sugar. However, he had undergone bypass surgery ten years ago. Our doctor has suggested targeted therapy is better for him as there is another mass found in the lungs too. Our doctor has prescribed Sutent 37.5 mg, to begin with, and slowly increase it to 50 mg.

However, due to our financial conditions, we cannot afford Sutent as it is pretty expensive for us. As we do not have any insurance. Is this the only drug available for this type of cancer, or do we have any other affordable and similar drugs with minimal side effects? We want to get your suggestion on this. Kindly help.

Hello,

Welcome to icliniq.com.

As per history given above. Your father as metastatic renal cell carcinoma. I would have liked to have few additional markers like his general condition, report of CBC (complete blood count) and LFT (liver function test), RFT (renal function test) to look at his risk score. In metastatic RCC, in first-line settings we have three TKI (Tyrosine kinase inhibitor) that are approved and commonly used. Namely, Sunitinib, Pazopanib, and Cabozantinib.

Sunitinib and pazopanib have almost the same progression-free and survival benefit. Cabozantinib has benefit in progression, but final overall survival was the same as sunitinib. Toxicities are bit different for Pazopanib with more chances of hepatitis, weight loss, and diarrhea. If you are not affording for Sunitinib, then I would say Pazopanib would be better as it is cheaper with similar benefits and slightly different toxicities. Cabozantinib is costlier and not yet available. I hope it helps. I would be happy to help you further if you have any more queries or questions regarding toxicities of these drugs.

Treatment plan

TKI.

Same symptoms don't mean you have the same problem. Consult a doctor now!

Dr. Pawar Satyajit Jalinder
Dr. Pawar Satyajit Jalinder

Medical oncology

Community Banner Mobile
By subscribing, I agree to iCliniq's Terms & Privacy Policy.

Read answers about:

anticancerrenal cancer

Ask your health query to a doctor online

Medical oncology

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.

This website uses cookies to ensure you get the best experience on our website. iCliniq privacy policy